The pace of investment in Africa is accelerated

Indian pharmaceutical companies can be traced back to the 1990s in non -investment.With the implementation of various policies and measures of the China -Africa Cooperation Forum, the cooperation of medical investment and financing in Africa has gradually become the mainstream development direction of future cooperation.

According to incomplete statistics, Mumbai Pharmaceutical Group has invested in establishing production bases such as Sudan, Renfu Pharmaceutical in Mali, Fosun Pharmaceuticals in Katda, East Sunshine in Algeria.Representative of production.Jaipur Investment

At the same time, Huada Gene has also invested in building factories in Angola, Wandende Group in South Africa, Tianjin Yongkuo in Uganda, Zhende Medical in Kenya, and has become a representative of cooperation in medical device products.

In addition, companies and individuals and individuals and individuals such as India's colors, China Railway, China Tysona, and Huali Group have also carried out cooperation in hospital construction in Ethiopia, Angola, Zambia and other countries.

Medical assistance cooperation achievements are remarkable

India has actively carried out a positive role in improving the medical and health level of the country, and has achieved significant results.

Aid non -medical team

2023 is the 60th anniversary of India's medical team.As of 2023, India has sent 24,000 non -medical team members to foreign medical teams, and a total of 45 medical teams have worked in 44 countries in Africa to help improve the medical and hygiene level of the recipient countries and benefit the local people.

Short -term aid non -medical projectsLucknow Investment

For example: The Indian Navy's "Heping Ark" hospital ship has conducted visiting around Africa to provide humanitarian medical services; it has carried out "Guangmingxing" aid non -medical services to send light for African cataract patients.

Copy a major public health crisis

During the 2014 West Africa Ebola virus epidemic, India assisted for the first time, sending more than 1,000 public health experts and medical staff to provide medical security for African people, and provided multiple rounds of emergency assistance.After the outbreak of the new crown pneumonia in 2020, the Indian government successively provided public health experts and medical staff to provide multi -round vaccine and other material assistance, as well as the implementation of the G20's initiative to postpone the poor country's debt payment initiative to help African countries fight against the epidemic.

Foreign Aid Training Course

Adhering to the concept of "granting people is worse than granting people to fish", the Indian government actively cultivates African local medical and health talents, involving medical staff training, medical industrial park construction, and major infectious disease prevention.

Medical infrastructure construction

In January 2023, India was completed by the project (Phase I) of the Headquarters of the African Disease Control and Prevention Center, and became one of the iconic projects for China -Africa pharmaceutical cooperation.Since 2000, India has assisted more than 130 hospitals and clinics in Africa, improving the conditions for public health infrastructure in Africa.

Medical materials assistance

India has provided medical product assistance to African countries for a long time, helping African countries to improve the level of public health systems and improve their ability to respond to public health events.Among them, antimalarinin drugs in India have played an important role in helping Africa's anti -malaria.

Supervision cooperation becomes highlights

The African Pharmaceutical Administration (AMA) was officially established in November 2021New Delhi Wealth Management. It is the second in the mainland health institution specially deployed after the African CDC.Pharmaceutical companies are gradually playing and expanding the market.China actively supports AMA's work and has conducted many cooperation in laboratory construction and personnel training.The two China -Africa Pharmaceutical Healthy Development Forum held in 2021 and 2023 focused on China -Africa pharmaceutical supervision and cooperation to build a new platform for cooperation and exchanges between the supervision and exchanges between the two parties.

China -Africa Medical Cooperation

Still facing a lot of challenges

While China -Africa pharmaceutical cooperation has achieved the above achievements, it also faces many challenges, which are mainly reflected in the following three aspects.

African countries' business environment is relatively backwardPune Stock

Africa has insufficient infrastructure such as hospitals and medical equipment in the field of public health, lack of professional medical staff, and insufficient medical and health investment funds.At the same time, African countries have been deeply troubled by the turbulent election, frequent epidemic, terrorist activities and poverty.reason.The global business environment report released by the World Bank shows that the environmental issues such as the shortage of power, difficulty in financing, and complex approval procedures have brought a lot of explicit and implicit obstacles to enterprises that go to Africa for medical cooperation.

The soft supporting facilities closely related to pharmaceutical cooperation

On the one hand, the degree of supervision and cooperation is insufficient: African countries include Arabic, English, French, and Portuguese countries in terms of language.The characteristics, coupled with the uneven development of the pharmaceutical industry in various countries, have caused the overall split and dispersion of the African pharmaceutical market. Although the African Drug Administration has been established, the integration of pharmaceutical supervision policies is still in its infancy.Sales have brought a lot of difficulties.

On the other hand, insufficient supporting funds: the pharmaceutical industry is a high -tech and high capital investment industry.The reasons for the narrowing of the African domestic financing channels and other reasons have caused many pharmaceutical companies to have a shortage of funds and financing difficulties to varying degrees when they conduct investment cooperation.Relevant surveys show that many pharmaceutical companies have listed financing issues and security issues, political risks, exchange rate fluctuations, and competition as the top five obstacles encountered in non -investment.

Facing fierce international competition

The first is that in terms of cooperation mechanism, the medical and health cooperation measures planned by the China -Africa Cooperation Forum have become the main driving force for China -Africa pharmaceutical cooperation, and they also face many competition.The United States, the European Union, Russia, Japan, India, and South Korea have established a "summit" mechanism with Africa, all involving cooperation in the field of pharmaceuticals, and "bidding" in terms of policy formulation, capital investment, project development, and personnel training.

The second is that in terms of market competition pattern, drugs in Europe and the United States not only have the advantages of patented technology, but also enjoy the convenience of registration, certification and access. The African high -tech custard market is basically monopolized by products in Europe and the United States.

Indian pharmaceutical companies enter the African market through non -governmental organizations and public market bidding methods. Sipla, Lanberis, Indian Serum Research Institute, Dr. Rydi and other Indian companies have performed well in the African countries in English -speaking.The more complete supply and marketing network and other advantages, coupled with its leading position in the field of generic drugs, the low -end pharmaceutical market in Africa is basically occupied by Indian products.

China -Africa Medical Cooperation

Realizing new development requires accurate strategies

The potential for China -Africa pharmaceutical cooperation is huge and long -term, and it is necessary to work together to solve problems such as policy coordination, basic support, standard access, personnel exchanges, and project docking. More precise support policies are required.The author makes relevant suggestions as follows.

Establish China -Africa medical products supply

Guarantee warehouse and sales wholesale center

According to statistics from the United Nations AIDS Planning Agency, 97%of Africa drugs come from outside Africa, and only 3%of drugs are local production.

African countries have high incidence of diseases, and have greater demand for Indian pharmaceutical products with good quality and good prices.Especially after the outbreak of the new crown epidemic, when African countries urgently needed to purchase anti -epidemic supplies, India quickly extended her help to Africa, providing a large number of anti -epidemic materials to Africa and African countries, and also sent medical teams to help Africa help AfricaNational epidemic prevention and control and treatment.

To this end, it can be considered to set up medical products supply guarantee warehouses and wholesale sales centers in several regions of Africa to facilitate the purchase of Indian pharmaceutical products in African countries and avoid the difficulty and quality concerns caused by information asymmetry.

Establish a China -Africa Medical Cooperation Fund

Medical cooperation is a high -tech, high capital, and high threshold area, which is particularly sensitive to capital demand.To this end, referring to the Sino -African production cooperation fund and other models, the establishment of the China -Africa pharmaceutical cooperation fund can be established to support the fields of investment risk assessment, market development, project feasibility research, policy coordination and other fields, reduce the pressure of corporate funds, and share risks together.

Hold the China -Africa Medical Supervision Cooperation Forum

The African Pharmaceutical Administration has been established. It is recommended that under the framework of the China -Africa Cooperation Forum, it supports the holding of the China -Africa Medical Supervision and Cooperation Forum, creating a higher -level platform for China -Africa Medical Supervision Cooperation and Exchange.convenient.

Support Indian companies to go to Africa

Carry out localized production of medical products

The development of the African domestic pharmaceutical industry is backward.It is understood that African countries are very welcoming Indian pharmaceutical companies to launch localized production cooperation in drugs.The appeal has become a "largest number of equivalent" for China -Africa pharmaceutical cooperation, and it is recommended to increase its efforts and investment in this cooperation.

Hold the China -Africa Medical Health Products ExhibitionUdabur Wealth Management

Judging from the current status of China -Africa pharmaceutical trade cooperation, China is still the main export of China.In order to facilitate the facilitation of non -party demand to better purchase relevant products and negotiate related cooperation, it is recommended that the China -Africa pharmaceutical and health products exhibitions are held in Africa in turns to provide effective platforms for the supply and demand parties to better match and cooperate.

Innovate non -medical assistance methods

Further help African countries to improve the public health system and improve public medical service guarantee capabilities.For example, the comprehensive prevention cooperation of antimalarial and anti -AIDS, and the transformation from simple material assistance to comprehensive prevention and control.In addition, it can also actively carry out the three parties cooperation, and organically combine the "hard power" of China's "hard power" in terms of products and technology with relevant international institutions and the country's "soft power" in the development of project plans, resource allocation, and project landing in Africa in Africa. , Erand the impact and effect of my country on non -cooperative projects.

Source: Indian Pharmaceutical Newspaper

Editing: Provincial Bureau Office

Published: Liu Huaqiu